Picture of abrdn China Investment logo

ACIC abrdn China Investment News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

REG - abrdn China Inv.Co. - Half-year Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230628:nRSb1160Ea&default-theme=true

RNS Number : 1160E  abrdn China Investment Company Ltd.  28 June 2023

abrdn China Investment Company Limited

Legal Entity Identifier (LEI): 213800RIA1NX8DP4P938

Half Yearly Report 30 April 2023

Performance Highlights

 

 NAV per Ordinary share                               NAV per ordinary share total return(A)
 As at 30 April 2023                                  Six months ended 30 April 2023
 580.9p                                               +14.0%
 As at 31 October 2022           512.0p               Year ended 31 October 2022                                   -37.0%

 Ordinary share price                                 Ordinary share price total return(A)
 As at 30 April 2023                                  Six months ended 30 April 2023
 497.0p                                               +11.5%
 As at 31 October 2022           448.0p               Year ended 31 October 2022                                   -35.5%

 Discount(A)                                          MSCI China All Share Index total return (in sterling terms)
 As at 30 April 2023                                  Six months ended 30 April 2023
 14.4%                                                +16.7%
 As at 31 October 2022           12.5%                Year ended 31 October 2022                                   +31.5%

 Net assets                                           Net gearing/(cash)(A)
 As at 30 April 2023                                  As at 30 April 2023
 £253.1m                                              2.6%
 As at 31 October 2022           £231.8m              As at 31 October 2022                                        -3.6%

 Revenue return per Ordinary share                    Ongoing charges ratio ('OCR')(AB)
 Six months ended 30 April 2023                       Forecast for year ending 31 October 2023
 -2.52p                                               1.09%
 Six months ended 30 April 2022  -0.47p               Year ended 31 October 2022                                   0.60%
 (A) Considered to be an Alternative Performance Measure.
 (B) The OCR for the year ended 31 October 2022 benefited from a six months'
 waiver of the management fee charged by abrdn plc and a twelve months' waiver
 of marketing fees.

 

Financial Calendar and Highlights

 

 Financial year end                                               31 October 2023
 Expected announcement of results for year ended 31 October 2023  February 2024
 Annual General Meeting (London)                                  April 2024

 

 

Performance (total return)
                                                 Six months ended  Year ended       31 October 2021 -
                                                 30 April 2023     31 October 2022  30 April 2023
                                                 %                 %                %
 Net asset value(A)                              14.0              -37.0            -28.2
 Share price(A)                                  11.5              -35.5            -28.1
 MSCI China All Share Index (in sterling terms)  16.7              -31.5            -20.1
 (A) Considered to be an Alternative Performance Measure.

 

 

 

Chairman's Statement
Overview

I am pleased to share with you the half-yearly report for abrdn China
Investment Company Limited ("the Company"), covering the six months to 30
April 2023 ("the Period"). During the Period, the Company's net asset value
("NAV") total return was 14.0% in sterling terms, while the share price total
return was 11.5%. The MSCI China All Shares Index, the Company's Reference
Index returned 16.7% over the Period. The share price discount to NAV was
14.5% at 30 April 2023.

Compared with the investment backdrop at our financial year end in October
2022, the Period covered by this half-yearly report was much more positive for
investors in Chinese equities.  Whilst not always evident from reporting in
the Western media, domestic sentiment now appears far more positive and
China's swift rollback of its zero-Covid measures during November and
December, and a full reopening of borders by early January, drove a strong
stock market rally with onshore and offshore Chinese companies seeing sharp
gains across the board. The Shanghai Stock Exchange A Shares Index rose 11% in
the six weeks following the lifting of Covid restrictions in early November.
The rally was particularly strong as it followed a severe test of investors'
nerves in the wake of a host of domestic concerns, including Covid-related
disruptions and growing pressure on the domestic real estate sector,
compounded by the worsening global economic environment.

Despite the positive early indicators, the economic recovery has not been as
smooth as many expected. The predicted rebound in consumption has failed to
match the market's high expectations. As a result, consumer companies,
including many of those held by the Company, have come under selling pressure
since February. The Company's Investment Manager believes that the bulk of
this recovery, aided by a restoration of consumer confidence, will happen in
the second half of this year and into 2024 as employment and income prospects
meaningfully improve for households. I am encouraged by the fact that the
Chinese Government publicly declared its intention to support growth at the
National People's Congress in March 2023. This implies that the policy
landscape is likely to remain accommodative in the months ahead.

Lawmakers have moved swiftly to ease pressure on a heavily indebted real
estate sector, which is both a major driver of economic growth and a key
source of personal wealth in China. Last year, the central government unveiled
a swathe of measures, including easing home-buying requirements for
individuals as well as a raft of policy tools, such as loan financing, bond
issuance and equity financing assistance, to help developers avoid the worst
effects of the liquidity crunch.

However, external pressures on China persist. There is still the looming
spectre of global recession as central banks raise interest rates to fight
rising inflation. China, where inflation is comparatively low compared to the
West, is one of the few nations that is still able to employ looser monetary
policy including lowering interest rates. Meanwhile, tensions simmer between
China and Taiwan, and continue to flare between the US and China, as was
illustrated by the US shooting down an alleged Chinese spy balloon that had
strayed into its airspace.

Against this backdrop, the Company's performance was supported by a rebound in
some sectors that had dragged down performance over the last financial year.
The financial sector had been one of the main detractors to performance for
the 12 months to 31 October 2022.  However, it was one of the strongest
performing sectors during the Period, after the Company's holdings,
particularly in the retail banks, rallied.  The performance of investments in
healthcare and materials were also positive during the Period. On a more
negative note, given the Company's consumer focus, consumer discretionary
stocks detracted, reflecting how the pace of recovery in consumption has, so
far, not lived up to investors' expectations.

In terms of positioning, the Company's Investment Manager continues to focus
on five core themes: Aspiration, Digitalisation, Going Green, Health and
Wealth.  These are aligned to the Chinese government's policy objectives and
tap into the vast consumer market and rising affluence of a growing middle
class in China. The Company's Investment Manager has reviewed exposure to
internet companies, increasing some positions and lowering the portfolio
weight to others, for stock-specific reasons. More detail on the performance
of the portfolio and changes to the holdings can be found in the Investment
Manager's Review.

China's reopening has had another direct positive impact for the Company. With
the lifting of Covid restrictions heralding the return of travel, one of the
Company's portfolio managers, Elizabeth Kwik, was able to update shareholders
in person at the Company's Annual General Meeting in London in April. This
provided our shareholders with a useful insight into the long-term outlook for
China and the differences between how the region is reported in the Western
media and the investment opportunities the Investment Manager sees locally.
The Board is also due to travel to China later this year in order to meet with
the abrdn investment team on the ground, as well as visit some of the
companies in the Investment Portfolio. By then, it will have been two years
since the mandate change, but it will be the first opportunity the Board has
had to travel to the region together and meet with the broader team in Hong
Kong and Shanghai.

Discount and Share Buy Backs

The discount at which the Company's shares trade relative to the NAV operated
in a narrow band between around -12% to -15% for most of the Period. At the
end of April 2023 the share price was trading at a discount of 14.4% and since
then the discount has remained unchanged.

The Board has continued to buy back shares in order to try to mute the
volatility of the discount. During the Period, 1,721,633 shares were bought
back at a total cost of £9.2m and a weighted average discount of 13.9%. This
represented 3.8% of the issued share capital and added 3.2p, or 0.51%, to the
Net Asset Value per Share. The shares are held in treasury.

The Company's share price has typically traded at a wider discount than that
of its peers, albeit with less variation in level than other trusts in the
sector.  Although, there are times when all the peers' discounts have widened
to match that of the Company.

Revenue Account & Dividend Outlook

In the previous financial year, the Company paid a dividend of 2.2 pence per
Ordinary share. The dividend was paid in order that the Company complied with
the rules governing investment trusts, which includes the requirement that
most of the net income is distributed to shareholders.

The surplus revenue last year arose largely as a result of the Company
benefiting from a waiver of the management fee following the merger with
Aberdeen New Thai Investment Trust PLC in November 2021. In the current year,
the Company will pay a full year of management fees and, as a result, the
charge in the current year is more representative of the ongoing expense than
last year.

Loan Facility and Gearing

In April 2022, the Company entered into a two year £15m, unsecured,
multi-currency, revolving loan facility with Industrial and Commercial Bank of
China, London Branch. The facility was undrawn at the start of the Period, but
£12.8m (CNH 106m) was drawn down in two tranches in December 2022 and January
2023. At the end of the Period, the cost of the funding was 4.11%. Since the
end of the Period, the remaining £2.2m (CNH 19.8m) of the facility has been
drawn. At the end of Period, the net gearing was 2.6%.

Change of Portfolio Administrator, Depositary, Registered Office, Custodian and Company Secretary

In April 2023, the Company completed the process of moving most of its support
functions to various entities within BNP Paribas S.A. Group ("BNP"). The
depositary and administration of the portfolio moved to BNP Paribas S.A.,
Guernsey Branch. The registered office of the Company moved to BNP Paribas
House, St Julian's Avenue, St Peter Port, Guernsey, GY1 1WA. The custodian was
also moved to BNP Paribas S.A. At the same time abrdn Holdings Limited was
appointed Company Secretary.

The Board decided to make these changes as BNP is the preferred service
partner of the Company's Investment Manager, abrdn plc, and currently BNP
provides these services to the majority of the investment companies that abrdn
manages. The Company will be able to access a more competitive rate card for
the provision of these vital services and at the same time, bringing the
Company into abrdn's administration model should result in improved reporting
to the Board.

I would like to thank the teams at Northern Trust (Guernsey) Limited and
Vistra Fund Services (Guernsey) Limited for the professional services and
support they have provided to the Company over the years, including through
the merger with Aberdeen New Thai in 2021 and, more recently, in the transfer
of responsibilities to BNP.

Outlook

It has been a challenging time for the Company since our mandate change in
November 2021.

However, the Chinese economy appears to be moving in the right direction.
After a lengthy period of social and travel restrictions, we believe there is
pent-up consumer demand in China. The reopening that is already underway
should lead to a multi-stage recovery, with a gradual revival of domestic
consumption. In turn, this should boost sectors ranging from tourism to
healthcare, and property to banks.

China's economic recovery appears to be underway, albeit at a slower and more
gradual pace than elsewhere in Asia. This recovery is aided by supportive
financial conditions. China's inflation is lower than surrounding countries,
meaning authorities have been more able to introduce accommodative monetary
and fiscal policies to support economic growth. Projections from the
International Monetary Fund ("IMF") earlier this year forecast that China's
economy will grow 5.2% in 2023 (compared with 3% in 2022). China's economy is
also expected to contribute one third of overall global growth. Although the
IMF also points out that "comprehensive macroeconomic policies and structural
reforms" are still required.

At the heart of China's economic growth is its rising middle class, supporting
the high-quality companies favoured by the Company's Investment Manager and
providing opportunities to invest in companies that are set to deliver
long-term capital growth. These companies are benefiting from rising affluence
leading to growth in consumption, growing digital integration and more
widespread technology adoption, the move to a greener, lower-carbon world,
greater demand for healthcare products, and structural growth in consumer
finance.

The Board and I remain convinced of China's long-term potential. We are
confident of the Company's Investment Manager's approach and believe the
portfolio is well positioned for the future.

 

Helen Green

Chairman

27 June 2023

 

 

 

 

Investment Manager's Review

 

Market Environment

The gloom surrounding Chinese equities and the economy has lifted and growth
is returning, albeit tentatively, after three years of the economic malaise
caused by the Covid-19 pandemic.

Optimism was in short supply as the Company's financial year got underway. The
central government's strict zero-Covid policy weighed heavily on share prices
for much of 2022 and disrupted swathes of the economy. Yet throughout stock
market history, patient investors who have been prepared to sit tight during
periods of volatility have often been rewarded. The turning point for China
came at the start of November 2022, the very beginning of the reporting
Period. Share prices surged after the government unexpectedly announced that
it was abandoning its seemingly steadfast commitment to its controversial
zero-Covid policy. Increased liquidity support for the struggling property
sector from the government and state-owned banks also improved investor
sentiment. Share prices rallied further in December as the prospect of an
economic reopening became a reality. All social distancing measures were
lifted and Covid-19 cases surged as a result, but China responded by
encouraging herd immunity. China's Center for Disease Control and Prevention
stated in January 2023 that the current wave of infections was "coming to an
end".

Investor spirits, buoyed by hopes of a rebound in economic growth, drove the
market higher and, with a strong rebound in share prices from November
onwards, February's profit-taking was perhaps inevitable. However, share
prices resumed their upward trajectory in March. Investors chased short-term
"hot themes", including those relating to ChatGPT, wider artificial
intelligence ("AI") opportunities and state-owned enterprise reforms, rotating
out of previous winners in the process. April saw the AI hype dissipate
somewhat as investors refocused on fundamentals.

Turning to broader economic themes, one of the most eye-catching statistics of
the Period was the reported GDP for the first quarter of 2023. It showed 4.5%
year-on-year growth, up from 2.9% in Q4 2022, and easily surpassed market
estimates of 4% annual growth. However, other data, such as an unexpected
decline in the Caixin Manufacturing Purchasing Managers' Index, generally
considered a reliable indicator of the strength of the Chinese economy,
declined from 51.6 in February to 50 in March, suggesting the recovery remains
patchy.

The concerns over the speed and strength of the economic recovery after the
easing of the zero-Covid policy has been reflected in company earnings.
First-quarter results from A-share companies largely pointed to recovery,
although the rebound is not yet proving to be as robust and broad-based as
expected. Based on our conversations with company management teams, we believe
that growth and recovery will be more pronounced as we move into the second
half of 2023.

Portfolio Performance

During the Period the Company's net asset value ("NAV") total return was
14.0%, which compares with the MSCI China All Shares Index, the Company's
Reference Index's, return of 16.7%. The Ordinary share price total return was
11.5%, as the discount to NAV at which the Company's Ordinary shares trade
widened to 14.4% from 12.5% at the start of the financial year.

The portfolio initially performed strongly after the re-opening of the Chinese
economy.  The market recognised our high-quality holdings and the opportunity
for them to benefit from the return to normal economic activity after three
years of stifled growth. However, profit-taking affected the portfolio in
February. Our limited exposure to artificial AI-related stocks also negatively
impacted performance as investors chased this "hot" trend in March. We do not
believe this trend is sustainable as we expect that investors will find
earnings delivery does not match their expectations, forcing them to refocus
on fundamentals. We have already seen this to a degree, as AI-related stocks
suffered a dip in April.

Stock-selection accounted for the Company's modest underperformance versus the
Reference Index. Our consumer discretionary holdings were the main source of
underperformance, although our information technology holdings also had a
negative impact on overall portfolio returns. Our financials and healthcare
holdings partially offset the rest of the portfolio's negative performance.

China Merchants Bank (CMB) and Tencent were the top two performers. CMB
rallied on the economic reopening while Tencent benefited from a recovery in
sentiment as regulation towards the internet sector eased. Elsewhere, Kweichow
Moutai benefited from strong initial interest in consumer stocks after the
re-opening. The company's special dividend and proposed capacity expansion
also boosted sentiment. Other holdings also benefited from the improved
investor confidence in consumption, including sportswear firm Li-Ning and
electrical appliance manufacturer Midea Group. Other beneficiaries of China's
re-opening included pan-Asian life insurer AIA and the Hong Kong Stock
Exchange.

Turning to the laggards, LONGi Green Energy, Yunnan Energy New Material and
Sungrow Power Supply were all affected by the weakness in renewable
energy-related stocks. Starpower Semiconductor suffered from softening
semiconductor prices. Not owning Ping An Insurance also hurt relative
performance, given its strong first-quarter results. Holding JD.com was
unhelpful based on market concerns over rising competition in e-commerce. This
may weigh on the stock over the near term, but we remain positive on the
company's long-term competitiveness.

Portfolio Activity

We believe our bottom-up stock-picking approach, grounded in fundamental
research and local expertise, provides an advantage in finding the best
quality companies in which to invest.  We engage collaboratively with
companies, prior to investment as well as part of our ongoing due diligence,
with the aim of sharing expectations and encouraging best practices.  Please
see the Case Studies of Engagement Activity below for examples of the work we
have been doing in this area.  We continue to construct and manage the
Company's portfolio based on the themes of Aspiration, Digital, Green, Health
and Wealth.  Whilst this approach will not prevent us from investing in
stocks where we see fundamental value, we would expect most of our holdings to
align to these key themes.

During the Period the Company received regulatory approval for a Qualified
Foreign Investor ("QFI") licence status, which provides access to the broader
Chinese equity market. As a result of this, we purchased two new stocks:
Centre Testing International and OPT Machine Vision. Centre Testing
International is a leading third-party testing company that enjoys stable and
diversified growth. OPT Machine Vision is a leading machine vision company
with good growth prospects, driven by the upgrade of automation manufacturing
in China.

We also initiated a position in PDD, owner of popular shopping app Pinduoduo.
It is gaining market share within China's ecommerce sector. We added to our
existing position in Alibaba Group in January, based on its attractive
valuation, easing regulatory pressures and an improving outlook thanks to the
earlier than expected reopening of the economy.

We exited positions in Anhui Conch Cement and GDS due to weakening conviction
and in view of better opportunities elsewhere.

Revenue Account

The loss for the Period was £1.1m compared to a loss of £0.221m for the same
period last year. While investment income was up almost 34% to £0.604m, the
prior year numbers benefited from a waiver of the management fee for the first
six months following the completion of the combination with Aberdeen New Thai
Investment Trust in November 2021. As a result, the current year management
fee charge is more representative of the ongoing expense than the prior year.

In 2022 90% of the income in the year was generated in the second half of the
Company's financial year and we expect that the split is likely to be similar
in the current year.

Outlook

The past three years have undeniably been challenging for China and those who
are invested in the country. Stringent social curbs and onerous travel
restrictions placed a great burden on the population. Now is the time for
optimism, however, even if there has not been a 'V' shaped economic rebound as
some had expected.

We see the Chinese consumer at the heart of the recovery. After a very long
period of widespread lockdowns, there is considerable pent-up consumer demand.
Furthermore, elevated household savings should provide a powerful tailwind for
consumer spending. As jobs and income prospects improve, we expect consumers
to spend their savings across different sectors, including tourism, travel,
healthcare and property.

The policy environment is another reason for optimism. Many Western economies
are still wrestling with stubbornly high inflation, resorting to repeated
interest-rate rises in a bid to manage the problem, with varying degrees of
success. In contrast, the inflation picture in China remains benign. This has
given the authorities the freedom to introduce accommodative monetary and
fiscal policies to support economic growth. In late April the central
government acknowledged the need to sustain the economic recovery at a meeting
of the Politburo. Policy guidance is therefore likely to remain supportive.
With growth in many developed Western economies set to slow as higher interest
rates bite, China represents a real counter-cyclical opportunity.

Finally, but crucially, valuations in China remain highly attractive. We
believe that quality companies - the type our investment process favours - are
still discounted by the market, but their prospects have improved
significantly and we believe that the market will recognise this valuation
discrepancy over time.

Across our five themes of Aspiration, Digital, Green, Healthcare and Wealth,
companies are still trading below historical valuations. These companies have
weathered the pandemic storm and continue to exhibit solid fundamentals. We
believe this is a great opportunity to invest in quality companies at
compelling valuations.

 

Nicholas Yeo and Elizabeth Kwik

abrdn Hong Kong Limited

27 June 2023

 

Ten Largest Investments

 

As at 30 April 2023
     Tencent Holdings Ltd                                                                                                                                              Kweichow Moutai Co Ltd

     (9.6% of portfolio value)                                                                                                                                         (6.3% of portfolio value)
     An innovative leader in China's internet sector with a strong presence in         The largest maker of Chinese alcohol spirit Baijiu, positioned in the
     fintech and cloud segments, backed by                                             ultra-premium space where there are few competitors. The company is well

an entrenched social media and payment ecosystem.                                placed to capture rising domestic consumption trends in China.

     Alibaba Group Holding Ltd                                                                                                                                         China Merchants Bank Co Ltd

     (5.2% of portfolio value)                                                                                                                                         (3.9% of portfolio value)
     The Chinese internet group is a global e-commerce company with leading            A best-in-class retail bank in China, offering diversified financial services
     platforms including Taobao and T-mall in the mainland. The company also has       with a solid track record and sound risk management practices.
     interests in logistics and media as

well as cloud computing platforms

and payments.

     Contemporary Amperex Technology Co Ltd                                                                                                                            Bank of Ningbo Co Ltd

     (3.3% of portfolio value)                                                                                                                                         (3.3% of portfolio value)
     The largest lithium battery maker in the world with leading technology and        A city bank focused on lending to small and medium enterprises in the affluent
     supply chain advantage, set to benefit from the rise of electric vehicles and     Ningbo-Zhejiang region. The bank has shown superior returns and asset quality
     energy storage.                                                                   over the years.

     Meituan                                                                                                                                                           AIA Group Ltd

     (3.0% of portfolio value)                                                                                                                                         (2.9% of portfolio value)
     A diversified online services platform with over 400 million users, offering      A leading pan-Asian life insurance company, it is poised to take advantage of
     services including food delivery, travel bookings and wedding planning. It is     Asia's growing affluence, backed by an effective agency sales force and a
     optimally placed to capture rising consumption in mainland China.                 strong balance sheet.

     JD.com Inc                                                                                                                                                        China Tourism Group Duty Free Corp Ltd

     (2.3% of portfolio value)                                                                                                                                         (2.3% of portfolio value)
     An online retailer with an edge in its strong logistics network. The company      China's largest duty-free operator
     has shown improving corporate governance and management quality over the
that is well placed to benefit from supportive government policy and
     years.
rising demand for duty-free cosmetics on the mainland.

 

 

 

Investment Portfolio

 

 

 As at 30 April 2023                                  ​                                             ​         ​
                                                                                                    Value     Value
 Company                                              Industry (sub-sector)                         (£'000)   (%)
 Tencent Holdings Ltd                                 Interactive Media & Services                  25,037    9.6
 Kweichow Moutai Co Ltd (A)                           Beverages                                     16,517    6.3
 Alibaba Group Holding Ltd                            Broadline Retail                              13,449    5.2
 China Merchants Bank Co Ltd (H)                      Banks                                         10,050    3.9
 Contemporary Amperex Technology Co Ltd (A)           Electrical Equipment                          8,586     3.3
 Bank of Ningbo Co Ltd (A)                            Banks                                         8,505     3.3
 Meituan Dianping - Class B                           Hotels, Restaurants & Leisure                 7,761     3.0
 AIA Group Ltd                                        Insurance                                     7,520     2.9
 JD.com Inc - Class A                                 Broadline Retail                              6,158     2.3
 China Tourism Group Duty Free Corp Ltd (AH)          Specialty Retail                              5,981     2.3
 Top ten investments                                                                                109,564   42.1
 Hong Kong Exchanges & Clearing Ltd                   Capital Markets                               5,356     2.1
 Ping An Bank Co Ltd (A)                              Banks                                         5,109     2.0
 Li Ning Co Ltd                                       Textiles, Apparel & Luxury Goods              4,796     1.8
 NetEase Inc                                          Entertainment                                 4,790     1.8
 Wanhua Chemical Group Co Ltd (A)                     Chemicals                                     4,755     1.8
 Sungrow Power Supply Co Ltd (A)                      Electrical Equipment                          4,697     1.8
 Shenzhen Mindray Bio-Medical Electronics Co Ltd (A)  Health Care Equipment & Supplies              4,655     1.8
 Proya Cosmetics Co Ltd (A)                           Personal Care Products                        4,629     1.8
 Aier Eye Hospital Group Co Ltd                       Health Care Providers & Services              4,622     1.8
 PDD Holdings Inc                                     Broadline Retail                              4,555     1.8
 Top twenty investments                                                                             157,528   60.6
 LONGi Green Energy Technology Co Ltd (A)             Semiconductors & Semiconductor Equipment      4,317     1.7
 Centre Testing International Group Co Ltd            Consulting Services                           4,249     1.6
 Sinoma Science & Technology Co Ltd (A)               Chemicals                                     4,097     1.6
 Wuxi Biologics Cayman Inc                            Health Care Providers & Services              3,903     1.5
 Glodon Co Ltd (A)                                    Software                                      3,869     1.5
 Fuyao Glass Industry Group Co Ltd (H)                Automobile Components                         3,828     1.5
 China Resources Land Limited                         Real Estate Management & Development          3,785     1.5
 Foshan Haitian Flavouring & Food Co Ltd (A)          Food Products                                 3,776     1.4
 China Vanke Co Ltd                                   Real Estate Management & Development          3,763     1.4
 Inner Mongolia Yili Industrial Group Co Ltd (A)      Food Products                                 3,602     1.4
 Top thirty investments                                                                             196,717   75.7
 By-health Co Ltd (A)                                 Personal Care Products                        3,488     1.3
 Midea Group Co Ltd (A)                               Household Durables                            3,452     1.3
 Shanghai M&G Stationery Inc (A)                      Commercial Services & Supplies                3,349     1.3
 Hefei Meiya Optoelectronic Technology Inc (A)        Machinery                                     3,343     1.3
 Chacha Food Co Ltd (A)                               Food Products                                 3,315     1.3
 Nari Technology Co Ltd (A)                           Electrical Equipment                          3,299     1.3
 Hundsun Technologies Inc (A)                         Software                                      3,210     1.2
 Zhejiang Weixing New Building Materials Co Ltd (A)   Building Products                             3,157     1.2
 Venustech Group Inc (A)                              Software                                      2,945     1.1
 Amoy Diagnostics Co Ltd (A)                          Biotechnology                                 2,865     1.1
 Top forty investments                                                                              229,140   88.1
 Silergy Corp                                         Semiconductors & Semiconductor Equipment      2,733     1.1
 Shenzhou International Group Holdings Ltd            Textiles, Apparel & Luxury Goods              2,672     1.0
 Jiangsu Hengrui Medicine Co Ltd (A)                  Pharmaceuticals                               2,576     1.0
 Yunnan Energy New Material Co Ltd (A)                Chemicals                                     2,576     1.0
 Estun Automation Co Ltd (A)                          Machinery                                     2,508     1.0
 Maxscend Microelectronics Co Ltd (A)                 Electronic Eqpt Instruments & Components      2,501     1.0
 StarPower Semiconductor Ltd (A)                      Semiconductors & Semiconductor Equipment      2,393     0.9
 China Meidong Auto Holdings Ltd                      Specialty Retail                              2,188     0.8
 Luxshare Precision Industry Co Ltd                   Electronic Eqpt Instruments & Components      1,991     0.8
 Hangzhou Tigermed Consulting Co Ltd (H)              Life Sciences Tools & Services                1,899     0.7
 Top fifty investments                                                                              253,177   97.4
 OPT Machine Vision Tech Co Ltd                       Electronic Eqpt Instruments & Components      1,863     0.7
 Yantai China Pet Foods Co Ltd (A)                    Food Products                                 1,772     0.7
 Zai Lab Ltd                                          Biotechnology                                 1,549     0.6
 Komodo Fund                                          Unit Trusts                                   1,049     0.4
 Wuliangye Yibin Co Ltd (A)                           Beverages                                     559       0.2
 Total investments                                                                                  259,969   100.0

 
Sector Breakdown as at 30 April 2023

 

                         Percentage
 Consumer Discretionary  21.1
 Consumer Staples        14.5
 Financials              14.4
 Industrials             12.8
 Communication Services  11.5
 Information Technology  9.9
 Healthcare              8.5
 Materials               4.4
 Real Estate             2.9

 

 

 

Case Studies of Engagement Activity

 

Chacha Food

(1.3% of portfolio value)

Chacha Food Company Limited ("Chacha") has been a leading player in China's
sizeable packaged roasted seeds and nuts market since it was founded in 1996.
Its main products include sunflower, watermelon and pumpkin seeds, beans,
pistachios, walnuts, almonds, and other nut products. The seeds segment has a
market share in excess of 50%, and accounts for 70% of

Chacha's sales.

Following management and strategy changes, including the return of a former
chairman, we believe that Chacha is well-positioned for further growth. Its
superior product quality, nimble organisational structure, strong branding,
and deep-rooted distribution channels should support its growth trajectory in
a fast-changing snack market.

Recently, we engaged with Chacha to understand its risk-management policies
better, and to encourage it to produce a standalone Environmental, Social and
Governance ("ESG") report. During our engagements, we were impressed with
Chacha's daily operations and its efforts to improve its ESG disclosure and
business integration.

Chacha has recently released its first ESG report. Within the report, Chacha
described its improving processes, including the use of recyclable packaging,
water-saving efforts in the manufacturing process, improvements in
supply-chain management and resulting client satisfaction scores.

We believe that this additional insight into Chacha will result in MSCI
upgrading its ESG rating. We continue to work with Chacha to help improve
these non-financial disclosures over time.

Shanghai M&G Stationery

(1.3% of portfolio value)

Shanghai M&G Stationery Inc ("SM&GS") is a leading stationery brand in
China with a market share of around 7%. SM&GS manufactures and sells
student and office stationery in three business lines:

·  Stationery business - which accounts for close to half of overall sales.

·  Office-supply business - an emerging business-to-business arm that trades
under the Colipu brand and generates over 40% of sales.

·  Zakka business - an emerging retail business with over 500 stores,
operating under the M&G Life and M&G Shops brands.

In 2021, we were the first investor to engage with SM&GS on its ESG
practices. We held multiple discussions with the SM&GS team on its
management of chemical safety, anti-corruption and bribery practices and
carbon emissions, as well as external ESG scores and disclosures.

Following our engagements, SM&GS released its first ESG report in 2022.
Based on our suggestions, it has built up its sustainability strategy and
implemented it across its business units. The company has improved in key
areas including chemical safety, by replacing and reducing its reliance upon
substances which are not sustainable. In supply chain management, it has
established ESG targets and introduced plans for its suppliers. It has created
a business conduct and anti-corruption system and introduced enhanced
disclosures.

SM&GS has established a highly competitive business, with potential for
further growth. The outlook for office stationery supply is positive, and
SM&GS is well-positioned to build upon the rapid growth already
experienced in its direct supply business. We expect the company to benefit
from its investments in recent years.  It is well placed to capitalise on the
structural domestic consumer trend towards premium products as disposable
incomes continue to rise. This is underpinned by its R&D expenditure and
premium product development, shared retail capabilities and timely consumer
insights.

 

Interim Management Report and Directors' Responsibility Statement

 

The Chairman's Statement and the Investment Manager's Review provide details
on the performance of the Company. Those reports also include an indication of
the important events that have occurred during the first six months of the
financial year ending 31 October 2023 and the impact of those events on the
condensed unaudited financial statements included in this Half-Yearly
Financial Report.

Details of investments held and the sector breakdown at the Period end is
shown above.

Principal Risks, Emerging Risks and Uncertainties

The Board has an ongoing process for identifying, evaluating and managing the
principal and emerging risks and uncertainties facing the Company.  The Board
has carried out a robust review of these risks.  Most of the principal risks
and uncertainties are market related and are no different from those of other
investment trusts that primarily invest in Chinese equities.  These are
contained within the Annual Report for the year ended 31 October 2022 and
comprise the following risk categories:

·  Risks relating to the Company;

·  Risks relating to the investment policy;

·  Risks relating to the Manager/Investment Manager;

·  Risks relating to regulation, taxation and the Company's operating
environment;

·  Internal Risks;

·  Emerging Risks; and

·  Failure to manage premium and/or discount.

The Board continues to monitor closely the political and economic
uncertainties which could affect markets, particularly the heightened interest
rate risk and the knock-on impact of the collapse of the likes of Silicon
Valley Bank, Credit Suisse and First Republic Bank.  The Board also considers
the impact of geopolitical risk on the Company and its portfolio, including
the ongoing tensions between China and Taiwan, China and the West, and
potential sanctions, as well as the ongoing war in Ukraine.

The Board is also very conscious of the risks emanating from increasing
Environmental, Social and Governance ("ESG") challenges together with climate
change and continues to monitor, through its Investment Manager, the potential
risk that investee companies may fail to keep pace with the rates of ESG and
Climate Change adaptation and mitigation that are required.

Going Concern

In accordance with the FRC's Guidance on Risk Management, Internal Control and
Related Financial and Business Reporting, the Directors have undertaken a
rigorous review of the Company's ability to continue as a going concern.

The Company's assets consist substantially of equity shares in companies
listed on recognised stock exchanges and in most circumstances are realisable
within a short timescale. The Company has adequate resources to continue in
operational existence for the foreseeable future and the ability to meet all
its liabilities and ongoing expenses from its assets.

The Directors are mindful of the principal and emerging risks and
uncertainties disclosed above, and review on a regular basis forecasts
detailing revenue and liabilities and the Company's operational expenses.
Having reviewed these matters, the Directors believe that the Company has
adequate financial resources to continue its operational existence for the
foreseeable future and for at least 12 months from the date of this Half
Yearly Report. Accordingly, they continue to adopt the going concern basis in
preparing the Half Yearly Report.

Related Party Transactions

There have been no material changes in the related party transactions
described in the 2022 Annual Report.  A summary of changes to the Company's
Service Providers during the Period is set out in the Chairman's Statement.
Please also see the Related Party Disclosures in note 10 to the financial
statements.

Responsibility Statement of the Directors in respect of the Half-Yearly Financial Report

The Disclosure Guidance and Transparency Rules require the Directors to
confirm their responsibilities in relation to the preparation and publication
of the Interim Management Report and Financial Statements.

The Directors confirm that to the best of their knowledge:

·  The condensed set of financial statements contained within the Half
Yearly financial report has been prepared in accordance with IAS 34 Interim
Financial Reporting and gives a true and fair view of the assets, liabilities,
financial position and return of the Company for the period ended 30 April
2023.

·  The Interim Management Report, together with the Chairman's Statement and
Investment Manager's Review, includes a fair review of the information
required by:

a)     DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being
an indication of important events that have occurred during the first six
months of the financial year and their impact on the condensed set of
financial statements, and a description of the principal risks and
uncertainties for the remaining six months of the year; and

b)    DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being
related party transactions that have taken place in the first six months of
the financial year and that have materially affected the financial position or
performance of the Company during that period, and any changes in the related
party transactions described in the last Annual Report that could do so.

The Directors are responsible for the maintenance and integrity of the
corporate and financial information included on the Company's website, but not
for the content of any information included on the website that has been
prepared or issued by third parties, and for the preparation and dissemination
of financial statements. Legislation in Guernsey governing the preparation and
dissemination of financial statements may differ from legislation in other
jurisdictions.

The Half-Yearly Financial Report was approved by the Board and the above
Directors' Responsibility Statement was signed on its behalf by the Chair.

 

For abrdn China Investment Company Limited

Helen Green

Chairman

27 June 2023

 

Condensed Unaudited Statement of Comprehensive Income

 

                                                                    Six months ended          Six months ended               Year ended
                                                                    30 April 2023             30 April 2022                  31 October 2022
                                                                    (unaudited)               (unaudited)                    (audited)
                                                                    Revenue  Capital  Total   Revenue  Capital    Total      Revenue  Capital    Total
                                                              Note  £'000    £'000    £'000   £'000    £'000      £'000      £'000    £'000      £'000
 Gains/(losses) on investments                                      -        33,044   33,044  -        (82,328)   (82,328)   -        (142,451)  (142,451)
 Gains/(losses) on currency movements                               -        283      283     -        (508)      (508)      -        (354)      (354)
 Net investment gains/(losses)                                      -        33,327   33,327  -        (82,836)   (82,836)   -        (142,805)  (142,805)
 Investment income                                                  604      -        604     452      -          452        4,108    -          4,108
 Investment management fees                                   10    (947)    -        (947)   (75)     -          (75)       (1,020)  -          (1,020)
 Other expenses                                                     (616)    -        (616)   (455)    -          (455)      (913)    -          (913)
 Operating (loss)/profit before finance costs and tax               (959)    33,327   32,368  (78)     (82,836)   (82,914)   2,175    (142,805)  (140,630)
 Finance costs                                                5     (182)    -        (182)   (107)    -          (107)      (109)    -          (109)
 Operating (loss)/profit before taxation                            (1,141)  33,327   32,186  (185)    (82,836)   (83,021)   2,066    (142,805)  (140,739)
 Taxation                                                           27       (56)     (29)    (36)     -          (36)       (215)    -          (215)
 Total (loss)/profit and comprehensive income for the period        (1,114)  33,271   32,157  (221)    (82,836)   (83,057)   1,851    (142,805)  (140,954)

 (Losses)/earnings per Ordinary share (pence)                 6     (2.52)p  75.28p   72.76p  (0.47)p  (177.94)p  (178.41)p  4.00p    (308.70)p  (304.70)p

 The total column of this statement represents the Company' s Statement of
 Comprehensive Income, prepared under IAS 34 Interim Financial Reporting. The
 revenue and capital columns, including the revenue and capital
 (losses)/earnings per Ordinary share data, are supplementary information
 prepared under guidance published by the Association of Investment Companies.
 All revenue and capital items in the above statement derive from continuing
 operations. No operations were acquired or discontinued during the period.
 The notes are an integral part of the condensed financial statements.

 

 

Condensed Unaudited Statement of Financial Position

 

                                                         As at          As at          As at
                                                         30 April 2023  30 April 2022  31 October 2022
                                                         (unaudited)    (unaudited)    (audited)
                                                   Note  £'000          £'000          £'000
 Non-current assets
 Investments at fair value through profit or loss        259,969        283,012        224,064
 Current assets
 Cash and bank                                           5,722          13,433         8,534
 Sales for future settlement                             -              1,555          -
 Other receivables                                       174            6              56
                                                         5,896          14,994         8,590
 Total assets                                            265,865        298,006        232,654
 Current liabilities
 Purchases for future settlement                         -              (1,244)        (222)
 Other payables                                          (551)          (261)          (564)
 Finance costs payable                                   (68)           (43)           (25)
 Bank loan                                               (12,181)       -              -
 Total liabilities                                       (12,800)       (1,548)        (811)
 Net assets                                              253,065        296,458        231,843

 Equity
 Share capital                                     7     138,216        154,462        147,744
 Capital reserve                                         119,603        147,708        87,739
 Revenue reserve                                         (4,754)        (5,712)        (3,640)
 Equity shareholders' funds                              253,065        296,458        231,843

 Net assets per Ordinary share (pence)             8     580.93         637.68         511.98

 The notes are an integral part of the condensed financial statements.

 

 

Condensed Unaudited Statement of Changes in Equity

 

 Six months ended 30 April 2023 (unaudited)  ​ ​ ​ ​ ​ ​
                                                                                Share     Capital    Revenue
                                                                                capital   reserve    reserve  Total
                                                     Notes                      £'000     £'000      £'000    £'000
 Balance at 1 November 2022                                                     147,744   87,739     (3,640)  231,843
 Profit/(loss) for the period                                                   -         33,271     (1,114)  32,157
 Buyback of shares                                   7                          (9,528)   -          -        (9,528)
 Dividends paid                                      9                          -         (1,407)    -        (1,407)
 Balance at 30 April 2023                                                       138,216   119,603    (4,754)  253,065

 Six months ended 30 April 2022 (unaudited) ​ ​ ​ ​ ​ ​
                                                                                 Share    Capital    Revenue
                                                                                capital   reserve    reserve  Total
                                                      Notes                     £'000     £'000      £'000    £'000
 Balance at 1 November 2021                                                     148,735   230,544    (5,491)  373,788
 Loss for the period                                                            -         (82,836)   (221)    (83,057)
 Scheme of reconstruction:
           Ordinary shares issued                                               62,037    -          -        62,037
           Ordinary shares repurchased                                          (55,291)  -          -        (55,291)
           Tender offer and share issue costs                    7              (177)     -          -        (177)
 Buyback of shares                                               7              (842)     -          -        (842)
 Balance at 30 April 2022                                                       154,462   147,708    (5,712)  296,458

 Year ended 31 October 2022 (audited) ​ ​ ​ ​ ​ ​
                                                                                 Share    Capital    Revenue
                                                                                capital   reserve    reserve  Total
                                                      Notes                     £'000     £'000      £'000    £'000
 Balance at 1 November 2021                                                     148,735   230,544    (5,491)  373,788
 (Loss)/profit for the year                                                     -         (142,805)  1,851    (140,954)
 Scheme of reconstruction:
           Ordinary shares issued                                               62,037    -          -        62,037
           Ordinary shares repurchased                                          (55,291)  -          -        (55,291)
           Tender offer and share issue costs                    7              (177)     -          -        (177)
 Buyback of shares                                               7              (7,560)   -          -        (7,560)
 Balance at 31 October 2022                                                     147,744   87,739     (3,640)  231,843

 The capital reserve at 30 April 2023 is split between realised gains of
 £193,654,000 and unrealised losses of £74,051,000 (30 April 2022 - realised
 gains of £218,088,000 and unrealised losses of £70,380,000; 31 October 2022
 - realised gains of £207,445,000 and unrealised losses of £119,706,000).
 The revenue reserve and realised element of the capital reserve represents the
 amount of the Company's retained reserves.
 The notes are an integral part of the condensed financial statements.

 

 

 

Condensed Unaudited Statement of Cash Flows

 

                                                                                  Six months ended  Six months ended  Year ended
                                                                                  30 April 2023     30 April 2022     31 October 2022
                                                                                  (unaudited)       (unaudited)       (audited)
                                                                                  £'000             £'000             £'000
 Operating activities
 Cash inflow from investment income                                               488               540               4,187
 Cash outflow from management expenses                                            (1,580)           (868)             (2,009)
 Cash outflow from withholding tax                                                (29)              (36)              (215)
 Net cash (used in)/from operating activities                                     (1,121)           (364)             1,963

 Cash flows from investing activities
 Cash outflow from purchase of investments                                        (55,608)          (378,180)         (446,496)
 Cash inflow from disposal of investments                                         52,525            244,052           311,504
 Net cash outflows from investing activities                                      (3,083)           (134,128)         (134,992)

 Cash flows from financing activities
 Dividends paid                                                                   (1,407)           -                 -
 Proceeds from bank borrowings                                                    12,181            -                 -
 Borrowing commitment fee and interest charges                                    (137)             (98)              (118)
 Scheme of reconstruction(A):
                             Ordinary shares issued                               -                 3,257             3,257
                             Ordinary shares repurchased                          -                 (55,291)          (55,291)
                             Tender offer and share issue costs                   -                 (388)             (388)
 Buyback of shares                                                                (9,528)           (842)             (7,338)
 Net cash inflow/(outflow) from financing activities                              1,109             (53,362)          (59,878)
 Decrease in cash and cash equivalents                                            (3,095)           (187,854)         (192,907)

 Analysis of changes in cash and cash equivalents during the period
 Opening balance                                                                  8,534             201,795           201,795
 Decrease in cash and cash equivalents as above                                   (3,095)           (187,854)         (192,907)
 Effect of foreign exchange                                                       283               (508)             (354)
 Cash and cash equivalents at end of period                                       5,722             13,433            8,534
 (A) Actual proceeds received as a result of the Scheme of reconstruction on 9
 November 2021 amounted to £3,257,000 with the remainder being received in the
 form of a UK Treasury Bill amounting to £57,980,000. The UK Treasury Bill was
 immediately sold on 10 November 2021 and subsequently deployed into Chinese
 equities.

 The notes are an integral part of the condensed financial statements.

 

 

Selected Explanatory Notes to the Condensed Unaudited Financial Statements

For the six-month period ended 30 April 2023

 

 1.  Reporting entity
     abrdn China Investment Company Limited (the "Company") is a closed-ended
     investment company, registered in Guernsey on 16 September 2009. The Company's
     registered office is BNP Paribas House St Julian's Avenue St Peter Port
     Guernsey GY1 1WA. The Company's Ordinary shares have a premium listing on the
     London Stock Exchange and commenced trading on 10 November 2009. The condensed
     interim financial statements of the Company are presented for the six months
     ended 30 April 2023.
     The Company invests in companies listed, incorporated or domiciled in the
     People's Republic of China ("China"), or companies that derive a significant
     proportion of their revenues or profits from China operations or have a
     significant proportion of their assets there. In furtherance of the investment
     policy, the portfolio will normally consist principally of quoted equity
     securities and depositary receipts although unlisted companies, fixed interest
     holdings or other non-equity investments may be held. Investments in unquoted
     companies will be made where the Manager has a reasonable expectation that the
     company will seek a listing in the near future. The portfolio is actively
     managed and may be invested in companies of any size and in any sector.
     Manager. Management of the Company's investment activities were delegated to
     abrdn Hong Kong Limited by abrdn Fund Managers Limited ("aFML") during the
     Period.
     Non-mainstream pooled investments ("NMPIs"). The Company currently conducts
     its affairs so that the Ordinary shares issued by the Company can be
     recommended by Independent Financial Advisers to ordinary retail investors in
     accordance with the Financial Conduct Authority's rules in relation to NMPIs
     and intends to continue to do so for the foreseeable future.

 

 2.  Basis of preparation
     Statement of compliance. The condensed interim financial statements have been
     prepared in accordance with IAS 34 Interim Financial Reporting and the
     Disclosure Guidance and Transparency Rules ("DTRs") of the UK's Financial
     Conduct Authority. They do not include all of the information required for
     full annual financial statements and should be read in conjunction with the
     financial statements of the Company as at and for the year ended 31 October
     2022. The financial statements of the Company as at and for the year ended 31
     October 2022 were prepared in accordance with International Financial
     Reporting Standards ("IFRS") as issued by the International Accounting
     Standards Board ("IASB"). The accounting policies used by the Company are the
     same as those applied by the Company in its financial statements as at and for
     the year ended 31 October 2022.
     Where presentational guidance set out in the Statement of Recommended Practice
     (SORP") for Investment Companies issued by the Association of Investment
     Companies ("AIC") in July 2022 is consistent with the requirements of IFRS,
     the Directors have prepared the financial statements on a basis compliant with
     the recommendations of the SORP.
     The "Total" column of the Condensed Unaudited Statement of Comprehensive
     Income is the profit and loss account of the Company. The "Revenue" and
     "Capital" columns provide supplementary information.
     This report will be sent to shareholders and copies will be made available to
     the public at the Company's registered office. It will also be made available
     on the Company's website: www.abrdnchina.co.uk.
     Going concern. The Directors have adopted the going concern basis in preparing
     the financial statements. The Board formally considered the Company's going
     concern status at the time of the publication of these financial statements
     and a summary of the assessment is provided below.
     Since the adoption of new investment policy, as approved by Shareholders at
     the EGM held on 26 October 2021, the Board considered it appropriate to reset
     the interval between Continuation Resolutions so that the next Continuation
     Resolution will be put to Shareholders at the annual general meeting of the
     Company to be held in 2027.
     The Directors believe that the Company has adequate resources to continue in
     operational existence for at least twelve months from the date of approval of
     this document. In reaching this conclusion, the Directors have considered the
     liquidity of the Company's portfolio of investments as well as its cash
     position, income and expense flows.
     As at 30 April 2023, the Company held £5.7 million in cash and £260.0
     million in investments. It is estimated that approximately 99% of the
     investments held at the period end could be realised in one month. The total
     operating expenses for the period ended 30 April 2023 were £1.6 million,
     which on an annualised basis represented approximately 1.09% of average net
     assets during the period. The Company also incurred 0.15% of finance costs. At
     the date of approval of this Report, based on the aggregate of investments and
     cash held, the Company has substantial operating expenses cover. The Company's
     net assets at 26 June 2023 were £228.0 million.
     The Company has a £15 million revolving credit facility with Industrial and
     Commercial Bank of China, London Branch ("ICBC") terminating in April 2024. As
     at 30 April 2023 £12,181,000 of the ICBC was drawn down at an interest rate
     of 4.108%. The liquidity of the Company's portfolio, as mentioned above,
     sufficiently supports the Company's ability to repay its borrowings at short
     notice.
     In light of the impact of the heightened interest rate risk and geopolitical
     risk, the Directors have fully considered and assessed the Company's portfolio
     of investments. A prolonged and deep market decline could lead to falling
     values of the investments or interruptions to cashflow. However, the Company
     currently has more than sufficient liquidity available to meet any future
     obligations.
     The Directors are satisfied that it is appropriate to adopt the going concern
     basis in preparing the financial statements and, after due consideration, that
     the Company is able to continue in operation for a period of at least twelve
     months from the date of approval of these condensed financial statements.
     Equity and reserves
     Share capital. Share capital represents the 1p nominal value of the issued
     share capital plus any share premium arising from the net proceeds of issuing
     shares less the aggregate cost of shares repurchased (to be held in treasury
     or for cancellation).
     Capital reserve. Profits achieved by selling investments and changes in fair
     value arising upon the revaluation of investments that remain in the portfolio
     are all charged to profit or loss in the capital column of the Condensed
     Statement of Comprehensive Income and allocated to the capital reserve. The
     capital reserve attributable to realised profits is also used to fund dividend
     distributions.
     Revenue reserve. The balance of all items allocated to the revenue column of
     the Condensed Statement of Comprehensive Income in each period is transferred
     to the Company's revenue reserve. The revenue reserve is also used to fund
     dividend distributions.

 

   Use of estimates, assumptions and judgements. The preparation of the condensed
   interim financial statements in conformity with IFRS requires management to
   make judgements, estimates and assumptions that affect the application of
   accounting policies and the to make judgements, estimates and assumptions that
   affect the application of accounting policies and the reported amounts of
   assets, liabilities, income and expenses. Actual results may differ from these
   estimates.
   Use of estimates and assumptions. Estimates and underlying assumptions are
   reviewed on an on-going basis. Revisions to accounting estimates are
   recognised in the period in which the estimates are revised and in any future
   periods affected.
   Classification and valuation of investments. Investments are designated as
   fair value through profit or loss on initial recognition and are subsequently
   measured at fair value. The valuation of such investments requires estimates
   and assumptions made by the management of the Company depending on the nature
   of the investments as described below and fair value may not represent actual
   realisable value for those investments.
   Use of judgements. In respect of note 11, the determination of what
   constitutes 'observable' requires significant judgement by the Company. The
   Company considers observable data to be that market data that is readily
   available, regularly distributed or updated, reliable and verifiable, not
   proprietary and provided by independent sources that are actively involved in
   the relevant market.
   Adoption of new and revised standards. At the date of approval of these
   condensed financial statements, there were no new or revised standards or
   interpretations relevant to the Company which came into effect.

 

 3.  Investments                                                            ​
     As the Company's business is investing in financial assets with a view to
     profiting from their total return in the form of increases in fair value,
     financial assets are designated as fair value through profit or loss on
     initial recognition. These investments are recognised on the trade date of
     their acquisition at which the Company becomes a party to the contractual
     provisions of the instrument. At this time, the best evidence of the fair
     value of the financial assets is the transaction price. Transaction costs that
     are directly attributable to the acquisition or issue of the financial assets
     are charged to profit or loss in the Statement of Comprehensive Income as a
     capital item. Subsequent to initial recognition, investments designated as
     fair value through profit or loss are measured at fair value with changes in
     their fair value recognised in profit or loss in the Statement of
     Comprehensive Income and determined by reference to:
     (i)                          investments quoted or dealt on recognised stock exchanges in an active market
                                  are valued by reference to their market bid prices;
     (ii)                         investments other than those in (i) above which are dealt on a trading
                                  facility in an active market are valued by reference to broker bid price
                                  quotations, if available, for those investments;
     (iii)                        investments in underlying funds, which are not quoted or dealt on a recognised
                                  stock exchange or other trading facility or in an active market, are valued at
                                  the net asset values provided by such entities or their administrators. These
                                  values may be unaudited or may themselves be estimates and may not be produced
                                  in a timely manner. If such information is not provided, or is insufficiently
                                  timely, the Investment Manager uses appropriate valuation techniques to
                                  estimate the value of investments. In determining fair value of such
                                  investments, the Investment Manager takes into consideration relevant issues,
                                  which may include the impact of suspension, redemptions, liquidation
                                  proceedings and other significant factors. Any such valuations are assessed
                                  and approved by the Directors. The estimates may differ from actual realisable
                                  values;
     (iv)                         investments which are in liquidation are valued at the estimate of their
                                  remaining realisable value; and
     (v)                          any other investments are valued at Directors' best estimate of fair value.
     Transfers between levels of the fair value hierarchy are recognised as at the
     end of the reporting period during which the change has occurred.
     Investments are derecognised on the trade date of their disposal, which is the
     point where the Company transfers substantially all the risks and rewards of
     the ownership of the financial asset. Gains or losses are recognised within
     profit or loss in the 'Capital' column of the Condensed Statement of
     Comprehensive Income. The Company uses the weighted average cost method to
     determine realised gains and losses on disposal of investments.

 

 4.  Operating segments
     IFRS 8, 'Operating segments' requires a 'management approach', under which
     segment information is presented on the same basis as that used for internal
     reporting purposes. The Board, as a whole, has been determined as constituting
     the chief operating decision maker of the Company. The Board has considered
     the requirements of the standard and is of the view that the Company is
     engaged in a single segment of business, which is investing predominantly in
     Chinese equities. The key measure of performance used by the Board is the Net
     Asset Value of the Company (which is calculated under IFRS). Therefore, no
     reconciliation is required between the measure of profit or loss used by the
     Board and that contained in the financial statements.
     The Board of Directors is responsible for ensuring that the Company's
     objective and investment strategy is followed. The day-to-day implementation
     of the investment strategy has been delegated to the Investment Manager, but
     the Board retains responsibility for the overall direction of the Company. The
     Board reviews the investment decisions of the Investment Manager at regular
     Board meetings to ensure compliance with the investment strategy and to assess
     the achievement of the Company's objective. The Investment Manager has been
     given full authority to make investment decisions on behalf of the Company in
     accordance with the investment strategy and analyses markets within a
     framework of quality, value, growth and change. The investment policy employed
     by the Investment Manager ensures that diversification within investments is
     taken into account when deciding on the size of each investment so the
     Company's exposure to any one company should never be excessive. The Company's
     positions are monitored as a whole by the Board in monthly portfolio
     valuations and at Board meetings. Any significant change to the Company's
     investment strategy requires shareholder approval.
     The Company has a diversified portfolio of investments and no single
     investment accounted for more than 10% of the Company's net assets at the
     Company's period end. The Investment Manager aims to identify investments
     which it considers are likely to deliver consistent capital growth over the
     longer term.

 

 5.  Bank loan and finance costs  ​ ​ ​ ​
     In April 2022, the Company entered into a £15 million unsecured multicurrency
     revolving loan facility with Industrial and Commercial Bank of China, London
     Branch ("the Lender") for a two-year period. The facility will be utilised for
     general working capital purposes and for the acquisition of investments in
     accordance with the Company's investment policy. Under the terms of the
     facility, the Company also has the option to increase the level of the
     commitment from £15 million to £30 million at any time, subject to the
     Lender's credit approval.
     During the Period, a total of CNH 106m was drawn down from the facility in two
     tranches in December 2022 and January 2023, which was equivalent to £12.2m as
     at 30 April 2023. At the Period end, the applicable interest rate on the
     amounts drawn down was 4.11%. Net gearing at the Period end was 2.6%.
     Subsequent to the Period end, a further CNH 19.8m (equivalent to the remaining
     £2.2m available from the facility) has been drawn down.

                                                        Six months       Six months
                                                        ended             ended           Year ended
                                                        30 April 2023    30 April 2022    31 October 2022
                                                        £'000            £'000            £'000
     Interest payable                                   152              66               70
     Facility arrangement fees and other charges        30               41               39
     Total finance costs                                182              107              109

     At 30 April 2023, interest payable of £65,000 (30 April 2022 - £43,000; 31
     October 2022 - £nil) was accrued in the Condensed Unaudited Statement of
     Financial Position.
     Restrictions imposed by the Lender in connection with the credit facility
     include the following financial covenants:
     a)               Total borrowings do not exceed 20% of the total assets at any time:
     b)               Its net asset value shall at all times be a minimum of £200 million; and
     c)               The aggregate value of the unlisted investments does not exceed 10% of the
                      aggregate value of the investments at any time.
     The Company does not have any externally imposed capital requirements other
     than disclosed above.

 

 6.  Earnings/(losses) per Ordinary share                    ​                 ​                 ​
                                                             Six months ended  Six months ended  Year ended
                                                             30 April 2023     30 April 2022     31 October 2022
                                                             pence             pence             pence
     Revenue return                                          (2.52)            (0.47)            4.00
     Capital return                                          75.28             (177.94)          (308.70)
     Total return                                            72.76             (178.41)          (304.70)

     The figures above are based on the following:

                                                             Six months ended  Six months ended  Year ended
                                                             30 April 2023     30 April 2022     31 October 2022
                                                             £'000             £'000             £'000
     Revenue return                                          (1,114)           (221)             1,851
     Capital return                                          33,271            (82,836)          (142,805)
     Total return                                            32,157            (83,057)          (140,954)

     Weighted average number of Ordinary shares in issue(A)  44,194,416        46,552,649        46,260,167
     (A) Excluding shares held in treasury.

 

 7.  Share capital                      ​               ​               ​               ​               ​
                                                        Ordinary                        Ordinary
                                                        shares of 1p    Allotted,       shares with
                                                        nominal value   issued and      voting          Treasury
     Six month ended 30 April 2023      Authorised      £'000           fully paid      rights(A)       shares
     Opening number of shares           Unlimited       622             62,172,947      45,283,575      16,889,372
     Purchase of own shares             -               -               -               (1,721,633)     1,721,633
     Closing number of shares           Unlimited       622             62,172,947      43,561,942      18,611,005

                                                        Ordinary                        Ordinary
                                                        shares of 1p    Allotted,       shares with
                                                        nominal value   issued and      voting          Treasury
     Six month ended 30 April 2022      Authorised      £'000           fully paid      rights(A)       shares
     Opening number of shares           Unlimited       546             54,618,507      45,965,159      8,653,348
     Scheme of reconstruction:
        Ordinary shares issued          -               76              7,554,440       7,554,440       -
        Ordinary shares repurchased     -               -               -               (6,894,773)     6,894,773
     Purchase of own shares             -               -               -               (134,749)       134,749
     Closing number of shares           Unlimited       622             62,172,947      46,490,077      15,682,870

                                                        Ordinary                        Ordinary
                                                        shares of 1p    Allotted,       shares with
                                                        nominal value   issued and      voting          Treasury
     Year ended 31 October 2022(B)      Authorised      £'000           fully paid      rights(A)       shares
     Opening number of shares           Unlimited       546             54,618,507      45,965,159      8,653,348
     Scheme of reconstruction:
        Ordinary shares issued          -               76              7,554,440       7,554,440       -
        Ordinary shares repurchased     -               -               -               (6,894,773)     6,894,773
     Purchase of own shares             -               -               -               (1,341,251)     1,341,251
     Closing number of shares           Unlimited       622             62,172,947      45,283,575      16,889,372
     (A) Excluding treasury shares.
     (B) Audited.

     Scheme of Reconstruction. On 9 November 2021, the Company completed and
     announced a Scheme of Reconstruction (the "Scheme"). As a result of the
     Scheme, the change in Ordinary share capital of the Company was as follows:
     Share issue - The Company acquired approximately £62 million of net assets
     from Aberdeen New Thai Investment Trust PLC in consideration for the issue of
     7,554,440 new Ordinary shares in the Company.
     Tender Offer - A total of 6,894,773 Ordinary shares were repurchased by the
     Company on 10 November 2021 under the Tender Offer and held in treasury at an
     aggregate cost to the Company of £55 million.
     The costs incurred in implementing the Scheme amounted to £1,058,000.
     Share capital account. The aggregate balance (including share premium)
     standing to the credit of the share capital account at 30 April 2023 was
     £138,216,000 (30 April 2022 - £154,462,000; 31 October 2022 - £147,444,000)
     Purchase of own shares. There were 1,721,633 Ordinary shares purchased during
     the six months ended 30 April 2023 (six months ended 30 April 2022 -
     134,749;  year ended 31 October 2022 - 1,341,251) at an aggregate cost to the
     Company of £9,528,000 (six months ended 30 April 2022 - £842,000;  year
     ended 31 October 2022 - £7,560,000).

 

 8.  Net asset value per Ordinary share ​ ​ ​ ​ ​ ​
     Net asset value per Ordinary share is based on net assets of £253,065,000 (30
     April 2022 - £296,458,000; 31 October 2022 - £231,843,000) divided by
     43,561,942 (30 April 2022 - 46,490,077; 31 October 2022 - 45,283,575) Ordinary
     shares in issue (excluding treasury shares) at the period end.
     The table below is a reconciliation between the NAV per Ordinary share
     announced on the London Stock Exchange and the NAV per Ordinary share
     disclosed in these condensed financial statements
                                                     As at 30 April 2023         As at 30 April 2022         As at 31 October 2022
                                                                   NAV per                     NAV per                     NAV per
                                                                   Ordinary                    Ordinary                    Ordinary
                                                     Net assets    share         Net assets    share         Net assets    share
                                                     £'000         p             £'000         p             £'000         p
     Published NAV                                   253,163       581.16        296,611       638.01        231,843       511.98
     Revaluation adjustments - delayed prices        (98)          (0.23)        (153)         (0.33)        -             -
     NAV as disclosed in these financial statements  253,065       580.93        296,458       637.68        231,843       511.98

 

 9.  Dividends paid
     On 17 March 2023, the Company paid to Shareholders the Interim dividend of
     3.2p per Ordinary share in respect of the Financial Year ended 31 October
     2022, amounting to £1,407,000.
     No dividend was paid for the Period (six months ended 30 April 2022 - nil;
     year ended 31 October 2022 - 3.20p paid on

17 March 2023).

 

 10.  Related party disclosures ​ ​ ​ ​
      Manager. Management fees payable are shown in profit or loss in the Condensed
      Unaudited Statement of Comprehensive Income.
      Total management fees of £947,000 (30 April 2022 - £75,000; 31 October 2022
      - £1,020,000) were paid and payable to the Manager for the period, with a
      balance of £295,000 (30 April 2022 - £75,000; 31 October 2022 - £291,000)
      being payable to the Manager at the period end.
      Following completion of the Scheme of Reconstruction, on 9 November 2021, the
      Company entered into a new management agreement (the 'Management Agreement')
      with abrdn Fund Managers Limited ('aFML'), pursuant to which the management
      fee payable by the Company to aFML will be calculated by reference to the
      market capitalisation of the Company, rather than its net assets (as was the
      case previously). The new management fee is structured on a tiered basis, with
      the first £150 million of market capitalisation being charged at 0.80%, the
      next £150 million being charged at 0.75%. and amounts thereafter being
      charged at 0.65%.
      Furthermore, aFML agreed to make a contribution to the costs of implementing
      the Scheme of Reconstruction by means of a waiver of the management fee for
      the first six months following the completion of the Scheme.
      The Management Agreement is terminable by either party on not less than six
      months' written notice at any time.
      Investments held by the Company which are managed by the abrdn Group. As at 30
      April 2023, the Company held the following investments managed by the abrdn
      Group:
                                                                                As at           As at           As at
                                                                                30 April 2023   30 April 2022   31 October 2022
                                                                                £'000           £'000           £'000
      Aberdeen Standard SICAV I - China A Share Equity Fund                     -               8,907           -

 

 11.  Fair value hierarchy                      ​                    ​                 ​                 ​
      IFRS 13 requires the Company to classify its investments in a fair value
      hierarchy that reflects the significance of the inputs used in making the
      measurements. IFRS 13 establishes a fair value hierarchy that prioritises the
      inputs to valuation techniques used to measure fair value. The hierarchy gives
      the highest priority to unadjusted quoted prices in active markets for
      identical assets or liabilities (Level 1 measurements) and the lowest priority
      to unobservable inputs (Level 3 measurements). The three levels of fair value
      hierarchy under IFRS 13 are as follows:
      Level 1              quoted prices (unadjusted) in active markets for identical assets or
                           liabilities;
      Level 2              inputs other than quoted prices included within Level 1 that are observable
                           for the asset or liability, either directly (that is, as prices) or indirectly
                           (that is, derived from prices);
      Level 3              inputs for the asset or liability that are not based on observable market data
                           (that is, unobservable inputs).
      The classification of the Company's investments held at fair value as at 30
      April 2023 is detailed in the table below:

                                                                     30 April          30 April          31 October
                                                                     2023              2022              2022
                                                                     £'000             £'000             £'000
      Instruments held at fair value through profit and loss
      Level 1                                                        258,920           281,974           222,745
      Level 2                                                        -                 -                 -
      Level 3                                                        1,049             1,038             1,319
      Total                                                          259,969           283,012           224,064

      The Company recognises transfers between levels of fair value hierarchy as at
      the date of the period end in which the change occurred.
      There were no investments transferred between levels during the period (30
      April 2022 and 31 October 2022 - £nil).
      Level 1 classification basis. Investments, whose values are based on quoted
      market prices in active markets, and therefore classified within Level 1,
      include listed equities in active markets. The Company does not adjust the
      quoted price for these instrument.
      Level 2 classification basis. Investments that trade in markets that are not
      considered to be active but are valued based on quoted market prices, dealer
      quotations or alternative pricing sources supported by observable inputs are
      classified within Level 2. These include monthly priced investment funds. The
      underlying net asset values of the openended funds included under Level 2 are
      prepared using industry accepted standards and the funds have a history of
      accepting and redeeming funds on a regular basis at net asset value. The net
      asset values of regularly traded open ended funds are considered to be
      reasonable estimates of the fair values of those investments and such
      investments are therefore classified within Level 2 if they do not meet the
      criteria for inclusion in Level 1.
      Level 3 classification basis. Investments classified within Level 3 have
      significant unobservable inputs, as they trade infrequently. The level 3
      figure consists of an investment in Komodo Fund. Komodo Fund is valued at the
      unadjusted net asset values provided by the administrator of that fund.
      The movement on the level 3 classified investments is shown below:
                                                                     Six months        Six months        Year to
                                                                     to 30 April       to 30 April       31 October
                                                                     2023              2022              2022
                                                                     £'000             £'000             £'000
      Opening balance                                                1,319             1,358             1,358
      Valuation adjustments(A)                                       (270)             (320)             (39)
      Closing balance                                                1,049             1,038             1,319
      (A) Total gains and losses for the period included in profit or loss relating
      to assets held at the end of the period.

 

 12.  Financial instruments - risk profile
      The principal risks relating to financial instruments held by the Company
      remain the same as at the Company's last financial year end.
 13.  Post Balance Sheet events
      Since the Period end, a further 484,714Ordinary shares have been bought back
      and held in treasury at a cost of £2,326,000.
 14.  Half-Yearly Report
      The financial information for the Period and for the six months ended 30 April
      2022 has not been audited.
      KPMG Channel Islands Limited has reviewed the financial information for the
      Period pursuant to the Auditing Practices Board guidance on Review of Interim
      Financial Information.

 

 15.  This Half Yearly Financial Report was approved by the Board on 27 June 2023.

 

 

 

 

 

Alternative Performance Measures ("APMs")

 

 Alternative performance measures are numerical measures of the Company's
 current, historical or future performance, financial position or cash flows,
 other than financial measures defined or specified in the applicable financial
 framework. The Company's applicable financial framework includes International
 Financial Reporting Standards and the Statement of Recommended Practice issued
 by Association of Investment Companies. The Directors assess the Company's
 performance against a range of criteria which are viewed as particularly
 relevant for closed-end investment companies.
 Discount to net asset value per Ordinary share ​ ​ ​
 The discount is the amount by which the share price is lower than the net
 asset value per share with debt at fair value, expressed as a percentage of
 the net asset value.

                                                    30 April 2023  31 October 2022
 NAV per Ordinary share                  a          580.93p        511.98p
 Share price                             b          497.00p        448.00p
 Discount                                (a-b)/a    14.4%          12.5%

 Net gearing/(cash)                      ​          ​              ​
 Net gearing/(cash) measures the total borrowings less cash and cash
 equivalents divided by shareholders' funds, expressed as a percentage. Under
 AIC reporting guidance cash and cash equivalents includes amounts due to and
 from brokers at the Period end.

                                                    30 April 2023  31 October 2022
 Borrowings (£'000)                      a          12,181         -
 Cash (£'000)                                       5,722          8,534
 Amounts due to brokers (£'000)                     -              (222)
 Amounts due from brokers (£'000)                   -              -
 Cash and cash equivalents               b          5,722          8,312
 Shareholders' funds (£'000)             c          253,065        231,843
 Net gearing/(cash)                      (a-b)/c    2.6%           (3.6%)

 Ongoing charges                         ​          ​              ​
 The ongoing charges ratio has been calculated in accordance with guidance
 issued by the AIC as the total of annualised investment management fees and
 administrative expenses and expressed as a percentage of the average daily net
 asset values with debt at fair value published throughout the year. The ratio
 for 30 April 2023 is based on forecast ongoing charges for the year ending 31
 October 2023.

                                                    30 April 2023  31 October 2022
 Investment management fees(A) (£'000)              1,791          1,020
 Administrative expenses(AB) (£'000)                1,138          913
 Less: non-recurring charges (£'000)                (15)           -
 Ongoing charges (£'000)                            2,914          1,933
 Average net assets (£'000)                         268,179        319,519
 Ongoing charges ratio                              1.09%          0.60%
 (A) The Ongoing charges ratio for the year to 31 October 2022 benefited from a
 six-month waiver of the management fee charged by abrdn plc and a 12 month
 waiver of marketing fees.
 (B) The Company's ongoing charges figure does not reflect any costs of the
 underlying funds as the underlying information is not readily available.

 The ongoing charges ratio provided in the Company's Key Information Document
 is calculated in line with the PRIIPs regulations which amongst other things,
 includes the cost of borrowings and transaction costs.
 Total return ​ ​ ​
 NAV and share price total returns show how the NAV and share price has
 performed over a period of time in percentage terms, taking into account both
 capital returns and dividends paid to shareholders. Share price and NAV total
 returns are monitored against open-ended and closed-ended competitors, and the
 Benchmark, respectively.

 Six months ended 30 April 2023                     NAV            Share price
 Opening at 1 November 2022              a          511.98p        448.00p
 Closing at 30 April 2023                b          580.93p        497.00p
 Price movements                         c=(b/a)-1  13.5%          10.9%
 Dividend reinvestment(A)                d          0.5%           0.6%
 Total return                            c+d        14.0%          11.5%

 Year ended 31 October 2022                         NAV            Share price
 Opening at 1 November 2021              a          813.20p        695.00p
 Closing at 31 October 2022              b          511.98p        448.00p
 Price movements                         c=(b/a)-1  (37.0%)        (35.5%)
 Dividend reinvestment(A)                d          0.0%           0.0%
 Total return                            c+d        (37.0%)        (35.5%)
 (A) NAV total return involves investing the net dividend in the NAV of the
 Company with debt at fair value on the date on which that dividend goes
 ex-dividend. Share price total return involves reinvesting the net dividend in
 the share price of the Company on the date on which that dividend goes
 ex-dividend.

 

By order of the Board

abrdn Holdings Limited

Company Secretary

27 June 2023

 

Please note that past performance is not necessarily a guide to the future and
the value of investments and the income from them may fall as well as rise.
Investors may not get back the amount they originally invested

 

 

For further information please contact:

Evan Bruce-Gardyne

Client Director, Investment Trusts, abrdn

Tel:  07720 073216

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR KDLFLXQLXBBB

Recent news on abrdn China Investment

See all news